Search Results - "Aikens, Timothy H."

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion by NAGARAKANTI, Rangadham, EZEKOWITZ, Michael D, REILLY, Paul A, YUSUF, Salim, CONNOLLY, Stuart J, OLDGREN, Jonas, YANG, Sean, CHERNICK, Michael, AIKENS, Timothy H, FLAKER, Greg, BRUGADA, Josep, KAMENSKY, Gabriel, PAREKH, Amit

“…The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial compared dabigatran 110 mg BID (D110) and 150 mg BID (D150) with warfarin for…”
Get full text

Dabigatran and Warfarin in Vitamin K Antagonist-Naive and -Experienced Cohorts With Atrial Fibrillation by EZEKOWITZ, Michael D, WALLENTIN, Lars, YUSUF, Salim, CONNOLLY, Stuart J, PAREKH, Amit, CHERNICK, Michael R, POGUE, Janice, AIKENS, Timothy H, YANG, Sean, REILLY, Paul A, LIP, Gregory Y. H

“…The comparison of anticoagulants dabigatran and warfarin might be most equitable in vitamin K antagonist (VKA)-naive patients. Warfarin and 2 doses of…”
Get full text

The evolving field of stroke prevention in patients with atrial fibrillation by Ezekowitz, Michael D, Aikens, Timothy H, Brown, Annamarie, Ellis, Zack

“…Vitamin K antagonists have been the standard in stroke prophylaxis in patients with atrial fibrillation for decades, but several limitations make it difficult…”
Get full text

Atrial Fibrillation: Outpatient Presentation and Management by EZEKOWITZ, Michael D, AIKENS, Timothy H, NAGARAKANTI, Rangadham, SHAPIRO, Timothy

Get full text

Response to Letter Regarding Article, “Atrial Fibrillation: Outpatient Presentation and Management” by Ezekowitz, Michael D., Aikens, Timothy H., Shapiro, Timothy, Nagarakanti, Rangadham

Get full text